The protein encoded by this gene is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. This gene product is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This encoded protein is thought to be involved in the regulation of mRNA splicing.
^ abNagase T, Seki N, Tanaka A, Ishikawa K, Nomura N (March 1996). "Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1". DNA Res2 (4): 167–74, 199–210. doi:10.1093/dnares/2.4.167. PMID8590280.
^Harada, K; Yamada A; Yang D; Itoh K; Shichijo S (September 2001). "Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation". Int. J. Cancer (United States) 93 (5): 623–8. doi:10.1002/ijc.1391. ISSN0020-7136. PMID11477570.
^Liu, Ying; Kim Byung Oh; Kao Chinghai; Jung Chaeyong; Dalton James T; He Johnny J (May 2004). "Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation". J. Biol. Chem. (United States) 279 (21): 21766–73. doi:10.1074/jbc.M314321200. ISSN0021-9258. PMID15031286.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Yang D, Nakao M, Shichijo S, et al. (1999). "Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients". Cancer Res.59 (16): 4056–63. PMID10463607.
Harada K, Yamada A, Yang D, et al. (2001). "Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation". Int. J. Cancer93 (5): 623–8. doi:10.1002/ijc.1391. PMID11477570.
Sasatomi T, Suefuji Y, Matsunaga K, et al. (2002). "Expression of tumor rejection antigens in colorectal carcinomas". Cancer94 (6): 1636–41. doi:10.1002/cncr.10421. PMID11920522.
Liu Y, Li J, Kim BO, et al. (2002). "HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110". J. Biol. Chem.277 (26): 23854–63. doi:10.1074/jbc.M200773200. PMID11959860.
Liu Y, Kim BO, Kao C, et al. (2004). "Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation". J. Biol. Chem.279 (21): 21766–73. doi:10.1074/jbc.M314321200. PMID15031286.
Brandenberger R, Wei H, Zhang S, et al. (2005). "Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation". Nat. Biotechnol.22 (6): 707–16. doi:10.1038/nbt971. PMID15146197.